Active drug shortages in the U.S. rose for the second consecutive quarter in 2026, reaching 223 in the first quarter, according to a recent report from the American Society of Health-System Pharmacists. Meanwhile, the FDA’s own database — which uses a narrower classification — lists 76 drugs currently in shortage, as of May 6.
The database is updated daily to reflect manufacturing recoveries, regulatory actions and how shortages are classified — not solely day-to-day availability at the hospital level.
Here are seven recent drug shortages, according to the FDA database:
- Cisatracurium besylate injection: Hospira, a Pfizer company, is discontinuing the 2- and 10-milligram/milliliter formulations, with supply expected to run out by late June. Posted May 6.
- Bupivacaine hydrochloride injection: Kindos Pharmaceuticals discontinued 2.5-, 5- and 7.5-milligram/milliliter presentations May 5.
- Lamotrigine extended-release tablets: Par Health discontinued all six strengths — 25 milligrams through 300 milligrams April 29.
- Crinecerfont capsules: Neurocrine Biosciences is discontinuing only the 25-milligram Crenessity capsule; the 50-, 100-milligram capsules and oral solution will remain on the market as of April 28.
- Etravirine tablets: Janssen discontinued the 100-milligram Intelence tablets April 28.
- Furosemide injection: Gland Pharma, distributed by Sagent Pharmaceuticals, discontinued the 10-milligram/milliliter formulation April 28.
- Palbociclib capsules: Pfizer is discontinuing the 75- and 100-milligram Ibrance capsules; the tablet formulation in both strengths will continue to be manufactured, as of April 22.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
